Clinical Trial Update: Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients [Phase 3]

View source ↗

Summary

Phase 3 trial in Chinese patients evaluated ilaprazole for treatment and prevention of peptic ulcer bleeding and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Bleeding
• Peptic Ulcer Disease

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Peptic Ulcer Hemorrhage | Phase 3 | Status: COMPLETED